Seventure Expects Uptick In Microbiome-Focused VC Investments
Executive Summary
Having closed a €160m venture fund focusing exclusively on microbiome-related fields – including pharmaceuticals, nutrition, biomarkers and diagnostics – Seventure Partners president and CEO Isabelle de Cremoux reveals how she expects to add another 10 companies this year to the nine she already has in her portfolio.